Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | Tel Aviv | Healthcare | Pharmaceuticals | ILS 78.02B | -45x | -0.55 | ILA 6,886 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kamada | Tel Aviv | Healthcare | Pharmaceuticals | ILS 1.15B | 19.5x | 0.09 | ILA 2,024 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rekah | Tel Aviv | Healthcare | Pharmaceuticals | ILS 154.10M | 23.6x | 0.07 | ILA 1,350 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Can Fite Biopharma | Tel Aviv | Healthcare | Pharmaceuticals | ILS 69.50M | -1.9x | -0.04 | ILA 3.40 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tikun Olam Cannbit | Tel Aviv | Healthcare | Pharmaceuticals | ILS 29.78M | -0.4x | -0.01 | ILA 36.80 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cannabotech | Tel Aviv | Healthcare | Pharmaceuticals | ILS 3.73M | ILA 205.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |